Article
Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.
Neuroscience letters - 17 Mar 2015
Kautto Mervi, Kampman Olli, Mononen Nina, Lehtimäki Terho, Haraldsson Susann, Koivisto Pasi A, Leinonen Esa
Abstract excerpt
Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET182C) polymorphisms are associated with susceptibility and treatment response in major depressive disorder (MDD). Thus, we examined association between these polymorphisms and susceptibility to treatment resistant depression, and treatment response in severe MDD patients treated with electroconvulsive therapy (ECT). In total, 119 Finnish patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.